Acorda Therapeutics, Inc.
ACORDelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001008848
Acorda Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Jun 23, 2023; 17 institutions reported holding it in 13F filings for Q1 2024, worth $2.13M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 17
- Q1 2024, +2 vs. previous quarter
- 13F value
- $2.13M
- Reported value at the end of Q1 2024
- Superinvestors holding
- 0
- At the end of Q1 2024
Superinvestors holding ACOR, Q1 2024
No superinvestor reported holding ACOR at the end of Q1 2024.
Latest insider trades
Open-market purchases and sales by Acorda Therapeutics, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2023 (view filing) | Mar 16-17 | 4 days | Cohen RonPresident and CEO | PPurchase | +20.2K | $0.6248 | +$12.6K | +15.6%149.8K after | 2 lots |
| Mar 21, 2022 (view filing) | Mar 17 | 4 days | Cohen RonPresident and CEO | SSale | −2.29K | $1.70 | −$3.89K | −1.7%129.6K after |
Top 10 13F holders, Q1 2024
The largest institutional positions in Acorda Therapeutics, Inc. at the end of Q1 2024; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Davidson Kempner Capital Management LP | 55,145 | $689.3K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 46,761 | $618.0K | 0.00% | +1,000+2.2% | Added |
| Acadian Asset Management LLC | 33,691 | $420.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 19,260 | $254.4K | 0.00% | +8,452+78.2% | Added |
| BlackRock Inc. | 6,107 | $80.7K | 0.00% | −521−7.9% | Reduced |
| Wells Fargo & Company | 3,736 | $49.4K | 0.00% | −5−0.1% | Reduced |
| Morgan Stanley | 1,137 | $15.0K | 0.00% | −39−3.3% | Reduced |
| Russell Investments Group, Ltd. | 300 | $3.75K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 106 | $1.40K | 0.00% | −192−64.4% | Reduced |
| Tower Research Capital LLC (TRC) | 103 | $1.36K | 0.00% | +103 | New |